Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : gary smith shorts and longs -- Ignore unavailable to you. Want to Upgrade?

To: backman who wrote (357)	2/8/1999 12:17:00 AM
From: Fortinwit	Read Replies (1) \| Respond to of 430

backman/thread: Longs: (none) Shorts: AFC (if it breaks below 50, no support for about 8 - 10 points) APCC (support @ -3 points) F.

To: backman who wrote (357)	2/8/1999 11:35:00 AM
From: Smilodon	Read Replies (2) \| Respond to of 430

Is anybody having success on the long side? I doing well this year, but almost all trades are shorts. I can't decide if that is just what the market is giving me, or is my long selection methodology too strict.

To: backman who wrote (357)	2/8/1999 11:05:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 430

I rarely recommend a short position in a biotech, being a bull for the sector, but ENMD should dip below $15/share (?) this week...... prnewswire.com Why would Children's and Folkman choose GZMO if they were pleased with ENMD? I think this statement probably tells it all...... "Genzyme possesses the manufacturing and commercialization expertise, the technical and financial resources, and the willingness to make the needed strategic commitment to develop this compound." Children's has become their own competitor.